[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"a2 Milk Company Ltd.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100591434","milk-free-from-a1-type--casein-on-inflammation-gastrointestinal-tolerance-and-pregnancy-outcomes-100591434",false,"NCT06980376","Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes","Effects of Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes: A Multi-Centre, Randomised, Open-Label, Prospective Study","Inclusion Criteria:\n\n* 20-35 years of age\n* Recruited at \\\u003C12 weeks of gestation\n* Intention to deliver at study site hospital\n* Singleton pregnancy\n* Able and willing to consume milk during pregnancy\n* Agree not to participate in another interventional clinical study during the present study\n\nExclusion Criteria:\n\n* Body mass index ≥ 35 at enrolment\n* Cow's milk intolerance or allergy\n* Significant systemic disorder (e.g., cardiac, respiratory, endocrinological, hemato-logic, or GI); pre-pregnancy diabetes, hypertension, or other medical conditions that preclude participation per the investigator's judgement\n* Taking any prescribed chronic medications\n* Participation in another clinical trial\n* Investigator uncertainty about the willingness or ability of the participant to comply with the protocol requirements\n* Taking probiotics at screening or two weeks before enrolment\n* Receiving any vaccine at screening or two weeks before enrolment",true,"FEMALE","20 Years","35 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","The aim of the study is to compare the effects of conventional Ultra High Temperature (UHT) milk containing both A1 and A2 type β-caseins (CON) with a2 UHT Milk containing A2 type β-casein only (A1PF) on inflammation, tolerance, and GI symptoms in pregnant women as well as infants' birth outcomes from 12 weeks' gestation up to 40 days post-birth.",[28],"Healthy Pregnant Women","RECRUITING","2026-02-04",{"date":32,"type":33},"2026-02-06","ACTUAL",{"date":35,"type":33},"2025-08-25",{"date":37,"type":22},"2026-09",{"name":39,"class":40},"a2 Milk Company Ltd.","INDUSTRY",6,""]